title: Secondary prevention trials in Alzheimer disease: the challenge of identifying a meaningful end point.
authors.affiliation: Departments of Statistics and Biostatistics and the Sanders-Brown Center on Aging, University of Kentucky, Lexington.
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Kryscio
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D002986:Clinical Trials as Topic / Q000592:standards*; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests / Q000592:standards*
chemical_list: D016229:Amyloid beta-Peptides